Christoph H. Gleiter

University Children's Hospital Tübingen — Germany

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

36h-index6.5kcitations108works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(11), Erythropoietin and Anemia Treatment(11), Electroconvulsive Therapy Studies(9), Neurotransmitter Receptor Influence on Behavior(7), Treatment of Major Depression(7)

Publications105 total

Predictors for guideline-nonadherencewith antithrombotic therapy in outpatients withchronic atrial fibrillation
Acta Medico-Biotechnica·2021Open Access
Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer’s Mice
Pharmaceuticals·2021· 29 citedOpen Access
Cell motility and migration as determinants of stem cell efficacy
EBioMedicine·2020· 43 citedOpen Access
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Cells·2020· 13 citedOpen Access
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
Neurotherapeutics·2019· 43 citedOpen Access
Interplay between Endothelin and Erythropoietin in Astroglia: The Role in Protection against Hypoxia
International Journal of Molecular Sciences·2014· 8 citedOpen Access
Intranasal Delivery of Bone Marrow-Derived Mesenchymal Stem Cells, Macrophages, and Microglia to the Brain in Mouse Models of Alzheimer's and Parkinson's Disease
Cell Transplantation·2014· 150 citedOpen Access
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials
European Journal of Cancer·2013· 28 cited
Age-Dependent Astroglial Vulnerability to Hypoxia and Glutamate: The Role for Erythropoietin
PLoS ONE·2013· 32 citedOpen Access
Quantifying the Effect of Covariates on Concentrations and Effects of Steady-State Phenprocoumon Using a Population Pharmacokinetic/Pharmacodynamic Model
Clinical Pharmacokinetics·2013· 3 cited
Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease
Rejuvenation Research·2011· 256 cited
No Dose Adjustment on Coadministration of the PDE4 Inhibitor Roflumilast With a Weak CYP3A, CYP1A2, and CYP2C19 Inhibitor: An Investigation Using Cimetidine
The Journal of Clinical Pharmacology·2010· 20 cited
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection
European Journal of Clinical Pharmacology·2010· 26 citedOpen Access
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Rejuvenation Research·2010· 157 cited
Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
The Journal of Clinical Pharmacology·2010· 33 cited
Pharmacogenetics of antimalarial drugs: effect on metabolism and transport
The Lancet Infectious Diseases·2009· 143 cited
MSc in clinical research – Danube University Krems
The Quality Assurance Journal·2009Open Access
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection
BMC Cancer·2009· 77 citedOpen Access
Intranasal delivery of cells to the brain
European Journal of Cell Biology·2009· 345 cited
The Targeted Oral, Once‐Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
The Journal of Clinical Pharmacology·2009· 17 cited
page 1 of 6Next →

Frequent Co-authors

Matthias Schwab(14), Lusine Danielyan(10), Bernd Kammerer(9), Marine Buadze(8), William H. Frey(7), Ali Lourhmati(7), Stefan Laufer(7), Richard Fux(6), Klaus Mörike(6), Barbara Proksch(5), Stephan Verleysdonk(5), Dino Bullinger(5), Richard Schäfer(4), Gayane Hrachia Buniatian(4), Ingolf Meineke(4), Elke Schaeffeler(4), Antje Frickenschmidt(4), H.M. Liebich(4), Hannelore Ehrenreich(3), Hilmar Prange(3)